(Q44634446)

4 December 2017

title

Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome (English)

1 reference

4 December 2017

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

25 March 2024

author name string

Sydney Tang

1

1 reference

4 December 2017

Man Kei Tam

3

1 reference

4 December 2017

Yiu Wing Ho

4

1 reference

4 December 2017

Anthony W. C. Tang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14582073

25 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14582073

25 March 2024

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0272638603010229?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

https://api.elsevier.com/content/article/PII:S0272638603010229?httpAccept=text/plain

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

American Journal of Kidney Diseases

25 March 2024

published in

1 reference

4 December 2017

volume

42

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

E13-5

1 reference

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome

25 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

Long-term cyclosporin A treatment in adults with refractory nephrotic syndrome

25 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

Tacrolimus in resistant primary membranous nephropathy - a report of 3 cases

25 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

FK506 suppresses neutrophil chemoattractant production by peripheral blood mononuclear cells

25 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

Anti-interleukin 8 antibody abolishes effects of lipoid nephrosis cytokine

25 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome

25 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

25 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

Cyclosporin-induced flushing in a renal transplant recipient resolving after substitution with tacrolimus

25 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

Dual effects of cyclosporine A on arachidonate metabolism by peritoneal macrophages. Phospholipase activation and partial thromboxane-synthase blockage

25 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.AJKD.2003.07.011

25 March 2024

Identifiers

1 reference

4 December 2017

1 reference